These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38433914)

  • 21. Single-cell transcriptome analysis reveals the effectiveness of cytokine priming irrespective of heterogeneity in mesenchymal stromal cells.
    Wan Z; Chen YF; Pan Q; Wang Y; Yuan S; Chin HY; Wu HH; Lin WT; Cheng PY; Yang YJ; Wang YF; Kumta SM; Lee CW; Lee OK
    Cytotherapy; 2023 Nov; 25(11):1155-1166. PubMed ID: 37715776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
    Asbach B; Kibler KV; Köstler J; Perdiguero B; Yates NL; Stanfield-Oakley S; Tomaras GD; Kao SF; Foulds KE; Roederer M; Seaman MS; Montefiori DC; Parks R; Ferrari G; Forthal DN; Phogat S; Tartaglia J; Barnett SW; Self SG; Gottardo R; Cristillo AD; Weiss DE; Galmin L; Ding S; Heeney JL; Esteban M; Jacobs BL; Pantaleo G; Wagner R
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells.
    Strauch V; Saul D; Berisha M; Mackensen A; Mougiakakos D; Jitschin R
    Stem Cells; 2020 Aug; 38(8):986-993. PubMed ID: 32346937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models.
    Grees M; Sharbi-Yunger A; Evangelou C; Baumann D; Cafri G; Tzehoval E; Eichmüller SB; Offringa R; Utikal J; Eisenbach L; Umansky V
    Oncoimmunology; 2018; 7(7):e1445457. PubMed ID: 29900058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photochemically-Mediated Inflammation and Cross-Presentation of
    Waeckerle-Men Y; Kotkowska ZK; Bono G; Duda A; Kolm I; Varypataki EM; Amstutz B; Meuli M; Høgset A; Kündig TM; Halin C; Sander P; Johansen P
    Front Immunol; 2022; 13():815609. PubMed ID: 35173729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of PD-1 Checkpoint Blockade and Botulinum Toxin Type A1 Improves Antitumor Responses in Mouse Tumor Models of Melanoma and Colon Carcinoma.
    Kwak S; Lee JY; Kim MJ; Lee HJ; Lee DK; Kang J; Kang WH; Son WC; Cruz DJM
    Immunol Invest; 2023 Nov; 52(6):749-766. PubMed ID: 37403798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.
    Avogadri F; Zappasodi R; Yang A; Budhu S; Malandro N; Hirschhorn-Cymerman D; Tiwari S; Maughan MF; Olmsted R; Wolchok JD; Merghoub T
    Cancer Immunol Res; 2014 May; 2(5):448-58. PubMed ID: 24795357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different priming strategies improve distinct therapeutic capabilities of mesenchymal stromal/stem cells: Potential implications for their clinical use.
    Miceli V; Zito G; Bulati M; Gallo A; Busà R; Iannolo G; Conaldi PG
    World J Stem Cells; 2023 May; 15(5):400-420. PubMed ID: 37342218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity.
    van Megen KM; van 't Wout ET; Lages Motta J; Dekker B; Nikolic T; Roep BO
    Front Immunol; 2019; 10():694. PubMed ID: 31001285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
    Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model.
    Gordy JT; Luo K; Zhang H; Biragyn A; Markham RB
    J Immunother Cancer; 2016; 4():96. PubMed ID: 28018602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses.
    Santos PM; Adamik J; Howes TR; Du S; Vujanovic L; Warren S; Gambotto A; Kirkwood JM; Butterfield LH
    J Exp Med; 2020 Jul; 217(7):. PubMed ID: 32369107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses.
    Jiang J; Xie D; Zhang W; Xiao G; Wen J
    J Transl Med; 2013 Dec; 11():300. PubMed ID: 24314011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes.
    Bikorimana JP; Abusarah J; Salame N; El-Hachem N; Shammaa R; Rafei M
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An optimized peptide vaccine strategy capable of inducing multivalent CD8
    Cho HI; Jung SH; Sohn HJ; Celis E; Kim TG
    Oncoimmunology; 2015 Nov; 4(11):e1043504. PubMed ID: 26451316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.
    Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E
    J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients.
    Hannani D; Leplus E; Laurin D; Caulier B; Aspord C; Madelon N; Bourova-Flin E; Brambilla C; Brambilla E; Toffart AC; Laulagnier K; Chaperot L; Plumas J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel CD73 Inhibitor SHR170008 Suppresses Adenosine in Tumor and Enhances Anti-Tumor Activity with PD-1 Blockade in a Mouse Model of Breast Cancer.
    Liu S; Li D; Liu J; Wang H; Horecny I; Shen R; Zhang R; Wu H; Hu Q; Zhao P; Zhang F; Yan Y; Feng J; Zhuang L; Li J; Zhang L; Tao W
    Onco Targets Ther; 2021; 14():4561-4574. PubMed ID: 34466002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination efficacy with marrow mesenchymal stem cell against cancer was enhanced under simulated microgravity.
    Li J; Chen J; Li X; Qian Y
    Biochem Biophys Res Commun; 2017 Apr; 485(3):606-613. PubMed ID: 28238782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.